- Monday, April 24, 2023
8:00 AM – 4:00 PM ET
Speaker Ready Room
8:00 AM – 4:00 PM ET
Speaker Ready Room
Location:Room 406, 4th Floor
8:00 AM – 5:00 PM ET
Registration Hours
8:00 AM – 5:00 PM ET
Registration Hours
Location:Franklin Hall Foyer, 4th Floor
9:00 AM – 9:30 AM ET
Prologue: Overcoming Critical Challenges of Evolving Biologics
9:00 AM – 9:30 AM ET
Prologue: Overcoming Critical Challenges of Evolving BiologicsLocation:Salon C, 5th FloorPrologue Speaker: – Merck & Co.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Nicole Buist, PhD (she/her/hers) – Merck & Co. ### 1529534###Prologue Speaker###Senior Director###Merck & Co.###Prologue Speaker: – Merck & Co.
### she/her/hers9:00 AM – 9:30 AM ET
Prologue: Overview of Biomarker and Bioanalytical Readouts for Safety and Efficacy Evaluation of AAV Gene Therapy
9:00 AM – 9:30 AM ET
Prologue: Overview of Biomarker and Bioanalytical Readouts for Safety and Efficacy Evaluation of AAV Gene TherapyLocation:Salon D, 5th FloorPrologue Speaker: – Sangamo Therapeutics
Advances in Therapeutic Development Across Modalities
Yanmei Lu, PhD (she/her/hers) – Sangamo Therapeutics ### 821735###Prologue Speaker###VP Biomarker and BioAnalysis###Sangamo Therapeutics###Prologue Speaker: – Sangamo Therapeutics
### she/her/hers9:30 AM – 11:00 AM ET
IP and Patents for Pharmaceutical Scientists & Entrepreneurs
9:30 AM – 11:00 AM ET
IP and Patents for Pharmaceutical Scientists & EntrepreneursLocation:Salon A, 5th FloorCareer Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
Career Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
Career Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
Career Development
Lara E. FitzSimmons, JD (she/her/hers) – Rakoczy Molino Mazzochi Siwik LLP (RMMS) ### 1876534###Career Center Speaker###Partner###Rakoczy Molino Mazzochi Siwik LLP (RMMS)###Career Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
### she/her/hers @@@ Paul J. Molino, JD (he/him/his) – Rakoczy Molino Mazzochi Siwik LLP (RMMS) ### 1876535###Career Center Speaker###Managing Partner###Rakoczy Molino Mazzochi Siwik LLP (RMMS)###Career Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
### he/him/his @@@ Thomas H. Ehrich, JD PhD (he/him/his) – Rakoczy Molino Mazzochi Siwik LLP (RMMS) ### 1876536###Career Center Speaker###Of Counsel###Rakoczy Molino Mazzochi Siwik LLP (RMMS)###Career Center Speaker: – Rakoczy Molino Mazzochi Siwik LLP (RMMS)
### he/him/his9:30 AM – 11:00 AM ET
Symposium: Innovation Based on Non-Traditional PlatformsModerator: – Teva Pharmaceuticals
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
9:30 AM – 11:00 AM ET
Symposium: Innovation Based on Non-Traditional PlatformsLocation:Salon C, 5th FloorModerator: – Teva Pharmaceuticals
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Haichen Nie, PhD – Teva Pharmaceuticals ### 1896152###Moderator###Associate Director###Teva Pharmaceuticals###Moderator: – Teva Pharmaceuticals
### 9:30 AM – 10:00 AM ET
Challenges and Strategies in Developing Biosimilar Drug ProductsLocation:Salon C, 5th FloorSpeaker: – Teva pharmaceuticals
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Mehran Yazdanian, PhD (he/him/his) – Teva pharmaceuticals ### 1820685###Speaker###VP###Teva pharmaceuticals###Speaker: – Teva pharmaceuticals
### he/him/his10:00 AM – 10:30 AM ET
Modeling Tools for Predicting Protein-Protein Interactions at High ConcentrationsLocation:Salon C, 5th FloorSpeaker: – University of Delaware
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Christopher Roberts, PhD – University of Delaware ### 624482###Speaker###Professor###University of Delaware###Speaker: – University of Delaware
### 10:30 AM – 11:00 AM ET
Excipient Phase Behavior - Implications on Protein StabilityLocation:Salon C, 5th FloorSpeaker: – University of Minnesota
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Raj Suryanarayanan, PhD (he/him/his) – University of Minnesota ### 1377916###Speaker###Professor###University of Minnesota###Speaker: – University of Minnesota
### he/him/his9:30 AM – 11:00 AM ET
Symposium: Recent Advances in Gene TherapyModerator: – PPD, A ThermoFisher Company
Advances in Therapeutic Development Across Modalities
9:30 AM – 11:00 AM ET
Symposium: Recent Advances in Gene TherapyLocation:Salon D, 5th FloorModerator: – PPD, A ThermoFisher Company
Advances in Therapeutic Development Across Modalities
Catherine Vrentas, PhD – PPD, A ThermoFisher Company ### 1650329###Moderator###Senior Research Scientist###PPD, A ThermoFisher Company###Moderator: – PPD, A ThermoFisher Company
### 9:30 AM – 10:00 AM ET
Immunogenicity Assessment and Mitigation of AAV-Based Gene TherapiesLocation:Salon D, 5th FloorSpeaker: – Janssen Research & Development, LLC
Advances in Therapeutic Development Across Modalities
Tong-Yuan Yang, PhD (he/him/his) – Janssen Research & Development, LLC ### 604583###Speaker###Senior Scientific Director ###Janssen Research & Development, LLC###Speaker: – Janssen Research & Development, LLC
### he/him/his10:00 AM – 10:30 AM ET
Translational and Dosing Considerations for Ocular AAV-Based Gene TherapyLocation:Salon D, 5th FloorSpeaker: – Johnson and Johnson
Advances in Therapeutic Development Across Modalities
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Speaker###Scientific Director###Johnson and Johnson ###Speaker: – Johnson and Johnson
### 10:30 AM – 11:00 AM ET
Biomarker and Bioanalytical Data from imagine-1:assessing PBGM01 for GM1 GangliosidosisLocation:Salon D, 5th FloorAdvances in Therapeutic Development Across Modalities
Yan G. Ni, PhD – Passage Bio ### 803355###Speaker###Executive Director###Passage Bio###Speaker: – Passage Bio
### 10:00 AM – 11:00 AM ET
Coffee Break in the Solution Center
10:00 AM – 11:00 AM ET
Coffee Break in the Solution CenterLocation:Franklin Hall, 4th Floor
10:00 AM – 11:00 AM ET
Hot Topic: Translational Intelligence in Omics: Exploring Advances in Genomics and MetabolomicsHot Topic Moderator: – Janssen BioTherapeutics
Hot Topic Speaker: – University of Florida, Department of Pathology
Hot Topic Speaker: – PPD
Advances in Therapeutic Development Across Modalities
10:00 AM – 11:00 AM ET
Hot Topic: Translational Intelligence in Omics: Exploring Advances in Genomics and MetabolomicsLocation:Salon B, 5th FloorHot Topic Moderator: – Janssen BioTherapeutics
Hot Topic Speaker: – University of Florida, Department of Pathology
Hot Topic Speaker: – PPD
Advances in Therapeutic Development Across Modalities
Sanjeev Bhardwaj, PhD – Janssen BioTherapeutics ### 1464295###Hot Topic Moderator###Senior Scientist###Janssen BioTherapeutics###Hot Topic Moderator: – Janssen BioTherapeutics
### @@@ Timothy J. Garrett, PhD – University of Florida, Department of Pathology ### 803624###Hot Topic Speaker###Associate Professor###University of Florida, Department of Pathology###Hot Topic Speaker: – University of Florida, Department of Pathology
### @@@ Anup Madan, PhD – PPD ### 1663785###Hot Topic Speaker###Director, Lab###PPD###Hot Topic Speaker: – PPD
### 10:00 AM – 4:30 PM ET
Solution Center Hours & Poster Presentations
10:00 AM – 4:30 PM ET
Solution Center Hours & Poster PresentationsLocation:Franklin Hall, 4th Floor
10:15 AM – 11:00 AM ET
Easy Automated Sample Prep for Regulated and Nonregulated Labs
10:15 AM – 11:00 AM ET
Easy Automated Sample Prep for Regulated and Nonregulated Labs Location:Learning Lab, Franklin HallPartner Presentation Speaker: – Agilent Technologies
Advances in Therapeutic Development Across Modalities
Kenda LJ Evans, Ph D (she/her/hers) – Agilent Technologies ### 1947017###Partner Presentation Speaker###Automation Product Specialist###Agilent Technologies###Partner Presentation Speaker: – Agilent Technologies
### she/her/hers11:00 AM – 12:30 PM ET
Light Lunch in the Solution Center
11:00 AM – 12:30 PM ET
Light Lunch in the Solution CenterLocation:Franklin Hall, 4th Floor
11:00 AM – 1:00 PM ET
Dedicated Solution Center Hours
11:00 AM – 1:00 PM ET
Dedicated Solution Center HoursLocation:Franklin Hall, 4th Floor
11:15 AM – 12:00 PM ET
LNP Characterization Using Field Flow Fractionation with Light Scattering Detection
11:15 AM – 12:00 PM ET
LNP Characterization Using Field Flow Fractionation with Light Scattering DetectionLocation:Learning Lab, Franklin HallPartner Presentation Speaker: – Wyatt Technology
Advances in Therapeutic Development Across Modalities
William Penny, PhD – Wyatt Technology ### 1944590###Partner Presentation Speaker###Regional Manager###Wyatt Technology###Partner Presentation Speaker: – Wyatt Technology
### 11:30 AM – 12:30 PM ET
Career Conversation Hosted By NIH/NINDS
11:30 AM – 12:30 PM ET
Career Conversation Hosted by NIH/NINDSLocation:Booth #412, Career Center, Franklin HallCareer Development
12:15 PM – 1:00 PM ET
Chromatographic Methods for the Analysis of RNA Therapeutics
12:15 PM – 1:00 PM ET
Chromatographic Methods for the Analysis of RNA TherapeuticsLocation:Learning Lab, Franklin HallPartner Presentation Speaker: – Waters Corporation
Advances in Therapeutic Development Across Modalities
Matthew Lauber, PhD – Waters Corporation ### 1916559###Partner Presentation Speaker###Senior Director###Waters Corporation###Partner Presentation Speaker: – Waters Corporation
### 12:30 PM – 1:30 PM ET
Special Poster Collection
12:30 PM – 1:30 PM ET
Special Poster CollectionLocation:Poster Forum 1; Franklin HallPoster Collection Host: – Genentech, Inc.
Advances in Therapeutic Development Across Modalities
Katie F. Maass, Ph.D. (she/her/hers) – Genentech, Inc. ### 847055###Poster Collection Host###Senior Principal Scientist, Clinical Pharmacology###Genentech, Inc.###Poster Collection Host: – Genentech, Inc.
### she/her/hers1:00 PM – 2:00 PM ET
Keynote: Bioanalytical and Biomarker Strategies for Sickle Blood Cell Gene Editing Therapies
1:00 PM – 2:00 PM ET
Keynote: Bioanalytical and Biomarker Strategies for Sickle Blood Cell Gene Editing TherapiesLocation:Salon E, 5th FloorKeynote Speaker: – Beam Therapeutics
Moderator: – BioAgilytix Labs
Advances in Therapeutic Development Across Modalities
Priya S. Chockalingam, Ph.D. (she/her/hers) – Beam Therapeutics ### 1820694###Keynote Speaker###VP, Head of Clinical BioAnalytics & Translational Sciences###Beam Therapeutics###Keynote Speaker: – Beam Therapeutics
### she/her/hers @@@ Lynn Kamen, PhD – BioAgilytix Labs ### 1680382###Moderator###Scientific Officer###BioAgilytix Labs###Moderator: – BioAgilytix Labs
### 1:00 PM – 2:00 PM ET
Keynote: Translation of Microneedle Patch Technology into the Clinic
1:00 PM – 2:00 PM ET
Keynote: Translation of Microneedle Patch Technology into the ClinicLocation:Salon C, 5th FloorKeynote Speaker: – Georgia Institute of Technology
Moderator: – Samford University
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Mark R. Prausnitz, PhD – Georgia Institute of Technology ### 605551###Keynote Speaker###Regents’ Professor###Georgia Institute of Technology###Keynote Speaker: – Georgia Institute of Technology
### @@@ Bernadette DSouza, PhD (she/her/hers) – Samford University ### 624468###Moderator###Associate Professor###Samford University###Moderator: – Samford University
### she/her/hers1:30 PM – 2:15 PM ET
Lipids, Learnings and Future Opportunities
1:30 PM – 2:15 PM ET
Lipids, Learnings and Future OpportunitiesLocation:Learning Lab, Franklin HallPartner Presentation Speaker: – Evonik Canada Inc.
Advances in Therapeutic Development Across Modalities
Zahra Merchant, PhD (she/her/hers) – Evonik Canada Inc. ### 1792340###Partner Presentation Speaker###Senior Scientist###Evonik Canada Inc.###Partner Presentation Speaker: – Evonik Canada Inc.
### she/her/hers2:00 PM – 2:30 PM ET
Coffee Break in the Solution Center
2:00 PM – 2:30 PM ET
Coffee Break in the Solution CenterLocation:Franklin Hall, 4th Floor
2:30 PM – 3:15 PM ET
Panel Discussion: Common Challenges in Bioanalytical Assay Validation/Development in CGTP
2:30 PM – 3:15 PM ET
Panel Discussion: Common Challenges in Bioanalytical Assay Validation/Development in CGTPLocation:Learning Lab, Franklin HallPartner Presentation Speaker: – KCAS Bioanalytical and Biomarker Services
Partner Presentation Speaker: – spfarmer@bdatasolutions.com
Partner Presentation Speaker: – Spirovant Sciences, Inc.
Partner Presentation Speaker: – Beam Therapeutics
Partner Presentation Speaker: – PPD Biomarkers
Partner Presentation Speaker: – BioAgilytix Labs
Advances in Therapeutic Development Across Modalities
Carrie A. Vyhlidal, PhD (she/her/hers) – KCAS Bioanalytical and Biomarker Services ### 1916655###Partner Presentation Speaker###Associate Director###KCAS Bioanalytical and Biomarker Services###Partner Presentation Speaker: – KCAS Bioanalytical and Biomarker Services
### she/her/hers @@@ Stephanie A. Pasas-Farmer, PhD (she/her/hers) – spfarmer@bdatasolutions.com ### 590019###Partner Presentation Speaker###President and Principal Consultant###spfarmer@bdatasolutions.com###Partner Presentation Speaker: – spfarmer@bdatasolutions.com
### she/her/hers @@@ Lillian Falese, MS – Spirovant Sciences, Inc. ### 1940580###Partner Presentation Speaker###Director###Spirovant Sciences, Inc.###Partner Presentation Speaker: – Spirovant Sciences, Inc.
### @@@ Kelly Colletti, PhD (she/her/hers) – Beam Therapeutics ### 1940581###Partner Presentation Speaker###Director, Preclinical Bioanalytics###Beam Therapeutics###Partner Presentation Speaker: – Beam Therapeutics
### she/her/hers @@@ David Kuhel, M.S. – PPD Biomarkers ### 1940582###Partner Presentation Speaker###Senior Research Scientist###PPD Biomarkers###Partner Presentation Speaker: – PPD Biomarkers
### @@@ Brian D. Bower, PhD – BioAgilytix Labs ### 1916709###Partner Presentation Speaker###Scientist III, Gene and Cell Therapy###BioAgilytix Labs###Partner Presentation Speaker: – BioAgilytix Labs
### 2:30 PM – 3:30 PM ET
Rapid Fire: Innovation Based on Non-Traditional PlatformsRapid Fire Moderator: – Merck & Co., Inc.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
2:30 PM – 3:30 PM ET
Rapid Fire: Innovation Based on Non-Traditional PlatformsLocation:Salon C, 5th FloorRapid Fire Moderator: – Merck & Co., Inc.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Jing Ling, PhD – Merck & Co., Inc. ### 1650352###Rapid Fire Moderator###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 2:30 PM – 2:45 PM ET
Targeted Drug Delivery using Edible Natural ProteinsLocation:Salon C, 5th FloorRapid Fire Speaker: – Philipps Universität Marburg
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Ahmed MA Mohamed (he/him/his) – Philipps Universität Marburg ### 1820667###Rapid Fire Speaker###PhD Candidate###Philipps Universität Marburg###Rapid Fire Speaker: – Philipps Universität Marburg
### he/him/his2:45 PM – 3:00 PM ET
Comparison of Trehalose and Sucrose in Preserving and Stabilizing Lyophilized Therapeutic ProteinsLocation:Salon C, 5th FloorRapid Fire Speaker: – Ashland Specialty Ingredients
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Fengyuan Yang, PhD – Ashland Specialty Ingredients ### 603502###Rapid Fire Speaker###Research Scientist###Ashland Specialty Ingredients###Rapid Fire Speaker: – Ashland Specialty Ingredients
### 3:00 PM – 3:15 PM ET
Mechanistic Understanding of the Impact of Sugar and Buffer Salts on the Physical Stability of solid biologicals formulationLocation:Salon C, 5th FloorRapid Fire Speaker: – Merck & Co., Inc.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Jing Ling, PhD – Merck & Co., Inc. ### 1650352###Rapid Fire Speaker###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Speaker: – Merck & Co., Inc.
### 3:15 PM – 3:30 PM ET
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality AssessmentLocation:Salon C, 5th FloorRapid Fire Speaker: – National Institute of Standards and Technology
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Joshua Imperatore, PhD – National Institute of Standards and Technology ### 1916543###Rapid Fire Speaker###NRC Postdoctoral Fellow###National Institute of Standards and Technology###Rapid Fire Speaker: – National Institute of Standards and Technology
### 2:30 PM – 3:30 PM ET
Rapid Fire: Recent Advances in Gene TherapyRapid Fire Moderator: – Novartis Institutes for BioMedical Research, Inc.
Advances in Therapeutic Development Across Modalities
2:30 PM – 3:30 PM ET
Rapid Fire: Recent Advances in Gene TherapyLocation:Salon E, 5th FloorRapid Fire Moderator: – Novartis Institutes for BioMedical Research, Inc.
Advances in Therapeutic Development Across Modalities
Robert Dodge, PhD – Novartis Institutes for BioMedical Research, Inc. ### 758596###Rapid Fire Moderator###Global Lead, Biologics Bioanalysis###Novartis Institutes for BioMedical Research, Inc.###Rapid Fire Moderator: – Novartis Institutes for BioMedical Research, Inc.
### 2:30 PM – 2:45 PM ET
Emerging Trends for Diagnostic Testing in Gene TherapiesLocation:Salon E, 5th FloorRapid Fire Speaker: – Novartis Pharmaceutical Corp.
Advances in Therapeutic Development Across Modalities
Jim Glick, PhD – Novartis Pharmaceutical Corp. ### 466128###Rapid Fire Speaker###Director, Diagnostic Sciences & Partnerships###Novartis Pharmaceutical Corp.###Rapid Fire Speaker: – Novartis Pharmaceutical Corp.
### 2:45 PM – 3:00 PM ET
Considerations for Developing and Validating an Anti-AAV9 ADA AssayLocation:Salon E, 5th FloorRapid Fire Speaker: – BioAgilytix
Advances in Therapeutic Development Across Modalities
Sara Alhakeem, PhD – BioAgilytix ### 1820681###Rapid Fire Speaker###Scientist/Bioanalytical Project Manager###BioAgilytix###Rapid Fire Speaker: – BioAgilytix
### 3:00 PM – 3:15 PM ET
Novel Alternatives to ELISPOT Assay for AAV Gene Therapy Clinical StudiesLocation:Salon E, 5th FloorRapid Fire Speaker: – Pfizer
Advances in Therapeutic Development Across Modalities
Ayuko Ota-Setlik, MS (she/her/hers) – Pfizer ### 1836158###Rapid Fire Speaker###Biomarker Clinical Assay Lead###Pfizer###Rapid Fire Speaker: – Pfizer
### she/her/hers3:15 PM – 3:30 PM ET
qPCR Biodistribution and Shedding Assessment Strategy in Gene Therapy StudiesLocation:Salon E, 5th FloorRapid Fire Speaker: – BioAgilytix Labs, LLC.
Advances in Therapeutic Development Across Modalities
Amanda L. Hays, Ph.D. – BioAgilytix Labs, LLC. ### 1529523###Rapid Fire Speaker###Scientific Officer###BioAgilytix Labs, LLC.###Rapid Fire Speaker: – BioAgilytix Labs, LLC.
### 3:00 PM – 4:00 PM ET
Hot Topic: Turbocharging Innovation in CMC - Driving Back to Rational Drug Design Hot Topic Moderator: – Merck & Co., Inc.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
3:00 PM – 4:00 PM ET
Hot Topic: Turbocharging Innovation in CMC - Driving Back to Rational Drug Design Location:Salon B, 5th FloorHot Topic Moderator: – Merck & Co., Inc.
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Wei Xu, Ph.D. – Merck & Co., Inc. ### 567494###Hot Topic Moderator###Director of Preformulation###Merck & Co., Inc.###Hot Topic Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:30 PM ET
CMC Strategy for Antibody Drug Conjugates: Challenges and Regulatory ConsiderationsLocation:Salon B, 5th FloorHot Topic Speaker: – Merck
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Weining Hu, MS (she/her/hers) – Merck ### 1820677###Hot Topic Speaker###AVP###Merck###Hot Topic Speaker: – Merck
### she/her/hers3:30 PM – 4:00 PM ET
Analytical Procedures for Biotherapeutics Product Variants: Scientific and Practical ConsiderationLocation:Salon B, 5th FloorGovernment Speaker: – US Food and Drug Administration
Turbocharging Innovation in CMC: Driving Back to Rational Drug Design
Jinhui Zhang, PhD – US Food and Drug Administration ### 603101###Government Speaker###Chemist###US Food and Drug Administration###Government Speaker: – US Food and Drug Administration
### 3:00 PM – 4:30 PM ET
Happy Hour Sponsored by B2S Life Sciences and Veloxity Labs
3:00 PM – 4:30 PM ET
Happy Hour Sponsored by B2S Life Sciences and Veloxity Labs
Location:Booth #308/310, Franklin Hall, 4th Floor
3:00 PM – 4:30 PM ET
Happy Hour Sponsored by Certara
3:00 PM – 4:30 PM ET
Happy Hour Sponsored by Certara
Location:Booth #215, Franklin Hall, 4th Floor
3:30 PM – 4:15 PM ET
AAPS Gene and Cell Therapy Products Community Membership Meeting
3:30 PM – 4:15 PM ET
AAPS Gene and Cell Therapy Products Community Membership MeetingLocation:Learning Lab, Franklin HallCommunity Leader: – Passage Bio
Community Leader: – Sangamo Therapeutics
Community Leader: – PPD, A ThermoFisher Company
Yan G. Ni, PhD – Passage Bio ### 803355###Community Leader###Executive Director###Passage Bio###Community Leader: – Passage Bio
### @@@ Yanmei Lu, PhD (she/her/hers) – Sangamo Therapeutics ### 821735###Community Leader###VP Biomarker and BioAnalysis###Sangamo Therapeutics###Community Leader: – Sangamo Therapeutics
### she/her/hers @@@ Catherine Vrentas, PhD – PPD, A ThermoFisher Company ### 1650329###Community Leader###Senior Research Scientist###PPD, A ThermoFisher Company###Community Leader: – PPD, A ThermoFisher Company
### 3:30 PM – 4:30 PM ET
Special Poster Collection
3:30 PM – 4:30 PM ET
Special Poster CollectionLocation:Poster Forum 1; Franklin HallPoster Collection Host: – Rutgers University
Patrick J. Sinko, Ph.D. – Rutgers University ### 602328###Poster Collection Host###Distinguished Professor###Rutgers University###Poster Collection Host: – Rutgers University
### 5:00 PM – 6:30 PM ET
Sustaining Partner Reception (by invitation only)
5:00 PM – 6:30 PM ET
Sustaining Partner Reception (by invitation only)Location:The Gallery, Hotel Main Lobby
